1. Repetitive transcranial direct current stimulation modulates the brain–gut–microbiome axis in obese rodents
- Author
-
Agata Ziomber-Lisiak, Katarzyna Talaga-Ćwiertnia, Agnieszka Sroka-Oleksiak, Artur D. Surówka, Kajetan Juszczak, and Magdalena Szczerbowska-Boruchowska
- Subjects
Leptin ,Pharmacology ,Body Weight ,Rodentia ,General Medicine ,Transcranial Direct Current Stimulation ,Rats ,Cholesterol ,Brain-Gut Axis ,Humans ,Animals ,Female ,Obesity ,Rats, Wistar - Abstract
Background Complex interactions between the brain, gut and adipose tissue allow to recognize obesity as a neurometabolic disorder. The recent data have shown that gut microbiota can play a potential role in obesity development. Transcranial direct current stimulation (tDCS) is a safe and non-invasive technique to modulate the activity of cerebral cortex and other connected brain areas also in context of appetite control. The objective of this study was to evaluate the effects of repetitive anodal tDCS (AtDCS) of prefrontal cortex on feeding behavior, metabolic status and selected phyla of gut microbiota in rats with obesity induced by high-calorie diet (HCD). Methods 32 female Wistar rats were equally divided into 4 subgroups depending on diet effect (lean versus obese) and type of stimulation (active versus sham tDCS versus no stimulation). Feed intake, body weight, blood lipoproteins and leptin levels as well as Firmicutes and Bacteroidetes in intestines and stool were examined. Results HCD changed feeding behavior and metabolic parameters typically for obesity-related ranges and resulted in an abundance of Firmicutes at the expanse of Bacteroidetes in the large intestine and stool. AtDCS decreased appetite, body weight, and cholesterol levels. In addition, AtDCS reduced ratio of the average number of Firmicutes to average number of Bacteroidetes in all examined tissues. Conclusions Repetitive AtDCS is not only effective for appetite restriction but can also modulate gut microbiome composition which demonstrates the existence of the brain–gut–microbiome axis and points at this technique as a promising complementary treatment for obesity. However, the effects should be further replicated in human studies.
- Published
- 2022
- Full Text
- View/download PDF